A Study of LY3154207 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Healthy Participants

Interventions

DRUG

LY3154207

Administered orally

DRUG

Placebo

Administered orally

DRUG

Itraconazole

Administered orally (twice daily on Day 3 and then once daily to Day 12) as a 10 mg/mL solution

Trial Locations (1)

PRA Health Sciences, Salt Lake City

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT02365571 - A Study of LY3154207 in Healthy Participants | Biotech Hunter | Biotech Hunter